Translations:Nicotinamide riboside/15/en

Revision as of 08:19, 8 April 2024 by FuzzyBot (talk | contribs) (Importing a new version from external source)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Commercialization

ChromaDex licensed patents in July 2012, and began to develop a process to bring NR to market as TruNiagen. ChromaDex has been in a patent dispute with Elysium Health over the rights to nicotinamide riboside supplements since 2016.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Nicotinamide_riboside/15/en&oldid=136384"